1.87
price down icon1.06%   -0.02
after-market Handel nachbörslich: 1.85 -0.02 -1.07%
loading

Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
41.69%
3.076
2.171 0.665 1.049 0.536
Operating Expenses
8.61%
41.73
38.42 37.38 33.67 34.65
Interest Income/Expense
1.47%
0.689
0.679 0.784 0.958 0.952
Benefits Costs and Expenses
100.00%
-
36.30 36.47 - -
Costs And Expenses
14.96%
41.73
36.30 36.47 33.67 34.65
Operating Income/Loss
6.63%
-38.65
-36.25 -36.71 -32.62 -34.11
Income/Loss From Continuing Operations Before Tax
109.01%
3.076
-34.13 -35.81 1.049 0.536
Income/Loss From Continuing Operations After Tax
8.28%
-36.95
-34.13 -35.81 -29.89 -31.66
Net Income/Loss
8.28%
-36.95
-34.13 -35.81 -29.89 -31.66
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.04%
129.73
129.68 2.9545 118.70 113.43
Diluted Average Shares
0.04%
129.73
129.68 2.9545 118.70 113.43
Basic Earnings Per Share
7.69%
-0.28
-0.26 -0.30 -0.25 -0.28
Diluted Earnings Per Share
7.69%
-0.28
-0.26 -0.30 -0.25 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):